U2BIO CO., LTD.
Provides diagnostic testing, digital health IT, and consumer products for clinics and labs.
221800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7221800006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 오금로 489 4층, 송파구
- Sector:
- Human health and social work activities
- Industry:
- Other residential care activities
Description
U2BIO CO., LTD. is a healthcare company that integrates biotechnology and information technology to provide advanced medical services. The company's primary activities include offering comprehensive in-vitro diagnostic testing services, such as general and molecular diagnostics, to clinical laboratories. In addition, U2BIO develops and supplies digital healthcare solutions and IT infrastructure, including laboratory management tools, designed to meet the needs of hospitals and clinics. The company also operates a biotechnology research center focused on microbiome science, leading to the development of consumer health products like premium probiotics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.0 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.5 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.3 MB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 180.9 KB | ||
| 2025-03-10 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 18.5 KB | ||
| 2025-02-20 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.1 KB | ||
| 2025-02-05 00:00 |
Regulatory News Service
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2024-12-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-12-16 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
|
Korean | 6.4 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.0 MB | ||
| 2024-10-23 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB |
Automate Your Workflow. Get a real-time feed of all U2BIO CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for U2BIO CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for U2BIO CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
